-
With a rapid acceleration of changes in the clinical trial industry, including international outsourcing, even experienced clinical trial professionals might find it a little confusing trying to figure out what sponsors want from their sites.
-
Data mining provided an ideal approach for predicting survival time for kidney dialysis patients, according to one study.
-
-
Women who are interested in long-term, reliable birth control now have a new option: The Food and Drug Administration (FDA) has just approved Implanon, the single-rod subdermal contraceptive implant.
-
Results from a new study indicate that consistent condom use offers protection against high-risk and low-risk types of human papillomavirus (HPV).
-
Your next patient is a 17-year-old female, who says she is interested in using an oral contraceptive (OC) to help control her acne. How do you discuss the use of the Pill in her acne treatment?
-
With approval from the FDA and a recommendation from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) in hand, providers are poised to offer the first vaccine specifically designed to prevent cervical cancer.
-
The latest U.S. estimates show that some 1 million to 1.2 million people in the United States are living with HIV/AIDS, with 24-27% undiagnosed and unaware of their HIV infection.
-
Power up the radar when it comes to bacterial vaginosis (BV) and trichomoniasis. The first national data on the subject show high prevalence of both reproductive tract infections.
-
In the August 2006 article, "Study looks at weight impact on OC efficacy," the apparent conclusion that weight is not associated with differential pregnancy rates is not supported by the data presented.
